CTMX - CytomX Therapeutics, Inc.
IEX Last Trade
1.095
0 0%
Share volume: 18,874
Last Updated: Thu 26 Dec 2024 08:29:03 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.10
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-08 | 2023-03-27 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-03-11 | 2024-05-08 | |
| Total revenue | 18.165 M | 16.915 M | 947.000 K | 23.499 M | 24.724 M | 26.384 M | 26.607 M | 41.463 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 18.165 M | 16.915 M | 947.000 K | 23.499 M | 24.724 M | 26.384 M | 26.607 M | 41.463 M | |
| -6.88% | -94.40% | 2,381.41% | 5.21% | 6.71% | 0.85% | 55.83% | |||
| Operating expenses | 42.907 M | 40.857 M | 29.632 M | 29.152 M | 28.072 M | 23.261 M | 27.213 M | 29.806 M | |
| Selling general and admin | 11.748 M | 10.490 M | 10.068 M | 7.977 M | 7.401 M | 6.813 M | 7.827 M | 7.754 M | |
| Research and development | 31.159 M | 30.367 M | 19.564 M | 21.175 M | 20.671 M | 16.448 M | 19.386 M | 22.052 M | |
| Total expenses | 42.907 M | 40.857 M | 29.632 M | 29.152 M | 28.072 M | 23.261 M | 27.213 M | 29.806 M | |
| -4.78% | -27.47% | -1.62% | -3.70% | -17.14% | 16.99% | 9.53% | |||
| Operating income | -24.742 M | -23.942 M | -28.685 M | -5.653 M | -3.348 M | 3.123 M | -606.000 K | 11.657 M | |
| Ebit | -24.742 M | -23.942 M | -28.685 M | -5.653 M | -3.348 M | 3.123 M | -606.000 K | 11.657 M | |
| Pretax income | -24.184 M | -23.296 M | -27.952 M | -3.311 M | -1.087 M | 5.815 M | 1.906 M | 13.840 M | |
| -3.67% | 19.99% | -88.15% | -67.17% | -634.96% | -67.22% | 626.13% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.823 M | 1.069 M | 49.000 K | |
| Net income basic | -24.184 M | -23.296 M | -27.952 M | -3.311 M | -1.087 M | 2.992 M | 837.000 K | 13.791 M | |
| 3.67% | -19.99% | 88.15% | 67.17% | 375.25% | -72.03% | 1,547.67% | |||
| Net income | -24.184 M | -23.296 M | -27.952 M | -3.311 M | -1.087 M | 2.992 M | 837.000 K | 13.791 M | |
| 3.67% | -19.99% | 88.15% | 67.17% | 375.25% | -72.03% | 1,547.67% |